Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries

Bente Glintborg, Stylianos Georgiadis, Anne Gitte Loft, Asta Linauskas, Hanne Lindegaard, Oliver Hendricks, Dorte V Jensen, Birgitte Lange Andersen, Kamilla Danebod, Anders Villumsen, Grith Eng, Charlotte Wiell, Natalia Manilo, Salome Kristensen, Johnny Raun, Jolanta Grydehøj, Stavros Chrysidis, Mette Nørgaard, Frank Mehnert, Niels Steen KroghMerete Lund Hetland

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
Sider (fra-til)846-848
Antal sider3
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind79
Udgave nummer6
Tidlig onlinedato28 feb. 2020
DOI
StatusUdgivet - jun. 2020

Citationsformater